Conclusion
Laboratory testing and vaccination have played a crucial role in the
prevention and control of brucellosis worldwide. Still,
laboratory-acquired infection and vaccination-related infection events
are worthy of attention. With the development of molecular biology
techniques and a deep understanding of the pathogenic mechanism ofBrucella , new vaccines based on genome engineering are expected
to replace traditional vaccines for brucellosis control. This report
serves as a reminder that occupational Brucella exposure is a
risk among clinical laboratory staff and veterinary personnel.
Clinicians, laboratory staff members, and public health officials should
be aware of diagnosis and treatment challenges of occupational
brucellosis and be prepared to manage brucellosis occupational exposures
and improve the awareness of brucellosis in high-risk populations. Only
the implementation of these measures will eliminate this occupational
infection.